Characterization of serum HER2 ECD level in patients with metastatic colorectal cancer

被引：0
|
作者：
Taniguchi, H. [1 ]
Hasegawa, H. [2 ]
Masuishi, T. [1 ]
Narita, Y. [1 ]
Komori, A. [1 ]
Kadowaki, S. [1 ]
Ura, T. [3 ]
Muro, K. [1 ]
机构：
[1] Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan
[2] Osaka Natl Hosp, Dept Gastroenterol & Hepatol, Osaka, Japan
[3] Aichi Canc Ctr, Nagoya, Aichi 464, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
10.1093/annonc/mdv233.229
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-232
引用
收藏
页数：1
相关论文
共 50 条
  • [11] The Role of HER2 Amplification Testing in Metastatic Colorectal Cancer
    Raghav, Kanwal P. S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (11) : 720 - 722
  • [12] HER2 in metastatic colorectal cancer: a new to target to remember
    Bitar, Lynn
    Zouein, Joseph
    Haddad, Fady Gh
    Eid, Roland
    Kourie, Hampig R.
    BIOMARKERS IN MEDICINE, 2021, 15 (02) : 133 - 136
  • [13] Reassessment of HER2 status in breast cancer patients at the time of metastatic disease by serum HER2 and HER2 status of circulating tumor cells
    Fehm, Tania
    TUMOR BIOLOGY, 2007, 28 : 22 - 22
  • [14] Serum HER2 Level in Epithelial Ovarian Cancer
    Mojtahedi, Zahra
    Dalaki, Sharareh Solati
    Dehaghani, Alamtaj Samsami
    Robati, Minoo
    Monabati, Ahmad
    Fattahi, Mohammad Javad
    Ghaderi, Abbas
    MIDDLE EAST JOURNAL OF CANCER, 2010, 1 (02) : 65 - 68
  • [15] Serum HER2 extracellular domain levels and HER2 circulating tumor cell status in patients with metastatic breast cancer
    Aurilio, Gaetano
    Sandri, Maria Teresa
    Pruneri, Giancarlo
    Zorzino, Laura
    Botteri, Edoardo
    Munzone, Elisabetta
    Adamoli, Laura
    Facchi, Giuseppina
    Cullura, Daniela
    Verri, Elena
    Rocca, Maria Cossu
    Zurrida, Stefano
    Iacovelli, Roberto
    Nole, Franco
    FUTURE ONCOLOGY, 2016, 12 (17) : 2001 - 2008
  • [16] Evaluation of circulating HER2 ECD and EGFR in patients with metastatic breast cancer treated with low aggressive chemotherapy
    Sandri, MT
    Johansson, HA
    Zorzino, L
    Salvatici, M
    Neumann, R
    Colleoni, M
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S94 - S95
  • [17] Serum levels of EGFR, HER2 and VEGF in colorectal cancer
    Garm, Swindler Karen-Lise
    Olsen, D. A.
    Jakobsen, A.
    Brandslund, I
    TUMOR BIOLOGY, 2006, 27 : 77 - 77
  • [18] The rational use of detection of CTC and serum HER2 ECD for HER2-positive advanced breast cancer patients.
    Zhou, Jinmei
    Wang, Tao
    Liu, Yi
    Zhang, Huiqiang
    Zhang, Shaohua
    Bian, Li
    Song, Santai
    Jiang, Zefei
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [19] The combined detection of CTC and serum HER2 ECD predict PFS for HER2-positive advanced breast cancer patients
    Jiang, Zefei
    Zhou, Jinmei
    Wang, Tao
    Liu, Yi
    Li, Lei
    Zhang, Huiqiang
    Zhang, Shaohua
    Bian, Li
    Song, Santai
    CANCER RESEARCH, 2015, 75
  • [20] Challenges in the clinical utility of the serum test for HER2 ECD
    Lam, Lian
    McAndrew, Nicholas
    Yee, Marla
    Fu, Ting
    Tchou, Julia C.
    Zhang, Hongtao
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2012, 1826 (01): : 199 - 208
12345